focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAssura Regulatory News (AGR)

Share Price Information for Assura (AGR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 42.92
Bid: 42.92
Ask: 43.02
Change: -0.24 (-0.56%)
Spread: 0.10 (0.233%)
Open: 42.16
High: 43.04
Low: 42.16
Prev. Close: 43.16
AGR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

2 Jul 2019 07:00

RNS Number : 1070E
Assura PLC
02 July 2019
 

2 July 2019

Assura plc

 

Trading Update

For the first quarter to 30 June 2019

 

Assura's high-quality portfolio and pipeline reinforced; GPI integration progressing well

 

Assura plc ("Assura"), the leading primary care property investor and developer, today announces its Trading Update for the first quarter to 30 June 2019.

 

Jonathan Murphy, CEO, said:

"Assura made good progress in the first quarter, further enhancing our high-quality portfolio of primary care properties. Our immediate pipeline of developments and acquisitions has never been stronger, while we disposed of 12 properties that were held for sale for cash proceeds of £17 million which was above book value.

 

"In May, we completed the purchase of primary care developer GPI and welcomed a talented new team into Assura. The acquisition boosted our immediate and extended development pipeline by an initial £92 million.

 

"We continue to source exciting opportunities to grow our portfolio and provide more of the fit-for-purpose primary care facilities that the NHS urgently needs to benefit patients and reduce pressure on the organisation.

 

"We remain confident in our outlook for the full year and in our longer-term prospects."

 

Developments and strategic acquisitions strengthen market-leading portfolio

· One development completed (Darley Dale) at a cost of £2.3 million and two moved to on site (Canterbury and St Leonards); total of 12 developments on site at the period end with a total development cost of £58 million.

· Two acquisitions completed in the period at a cost of £5.5 million.

· 12 disposals completed for £17 million cash consideration at a small premium to book value.

 

GPI acquisition expands pipeline

· Current portfolio of 554 properties.

· Immediate development pipeline of £77 million.

· Immediate acquisitions pipeline increased to £64 million, compared with £41 million at March 2019.

· Total immediate pipeline value, including on site developments, of £199 million up from £142 million at the year end.

 

Active portfolio management delivering value

· Six lease re-gears agreed on £0.3 million of rent, adding weighted average of 10 years WAULT on those properties.

· Annualised rent roll at £102.1 million post disposals.

 

Strong financial position

· As at 30 June 2019 gross debt £730 million with undrawn facilities of £230 million plus cash balance of £47.5 million.

 

 

 

ENDS

For further information, please contact:

 

Assura plc:

Jayne Cottam, CFOOrla Ball, Company SecretaryDavid Purcell, Head of Financial Reporting

 

Tel: 01925 420 660

 

Finsbury:

Gordon Simpson

James Thompson

 

Tel: 0207 251 3801

 

This announcement contains inside information as defined in Article 7 of the EU Market Abuse Regulation No 596/2014 and has been announced in accordance with the Company's obligations under Article 17 of that Regulation.

 

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 31 March 2019, Assura's property portfolio was valued at £1,979 million.

 

Further information is available at www.assuraplc.com

 

*EPRA is a registered trademark of the European Public Real Estate Association.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTLLFLRDEILIIA
Date   Source Headline
15th Dec 20143:12 pmRNSAcquisition of three medical centres for £11.5m
3rd Dec 20147:00 amRNSAssura completes Kidderminster purchase agreement
2nd Dec 20143:22 pmRNSNotification of Major Interest In Shares
28th Nov 20144:40 pmRNSSecond Price Monitoring Extn
28th Nov 20144:35 pmRNSPrice Monitoring Extension
28th Nov 201410:05 amRNSTotal Voting Rights
27th Nov 20142:26 pmRNSConfirmation of Quarterly Interim Dividend
25th Nov 20147:00 amRNSInterim Results 2014
6th Nov 20147:00 amRNS£63m acquisition and £21m development agreement
3rd Nov 20143:47 pmRNSNotification of Major Interest in Shares
3rd Nov 201412:20 pmRNSNotification of Major Interest in Shares
3rd Nov 20147:00 amRNSAssura adds four new medical centres
22nd Oct 20145:42 pmRNSNotification of Major Interest in Shares
22nd Oct 20144:52 pmRNSNotification of Major Interest in Shares
22nd Oct 201410:23 amRNSNotification of Major Interest in Shares
20th Oct 20141:00 pmRNSNotification of Major Interest in Shares
17th Oct 20149:25 amRNSNotification of Major Interest in Shares
16th Oct 20145:37 pmRNSNotification of Major Interest in Shares
16th Oct 20145:32 pmRNSNotification of Major Interest in Shares
16th Oct 20141:29 pmRNSDirector/PDMR Shareholding
16th Oct 20141:29 pmRNSTR-1: Notification of Major Interest in Shares
16th Oct 201412:38 pmRNSNotification of Major Interest in Shares
15th Oct 20142:58 pmRNSConfirmation of Quarterly Interim Dividend
14th Oct 20143:36 pmRNSResult of Extraordinary General Meeting
14th Oct 20143:15 pmRNSNotification of Major Interest in Shares
13th Oct 20144:27 pmRNSTR-1: Notification of Major Interest in Shares
13th Oct 20142:54 pmRNSTR-1: Notification of Major Interest in Shares
10th Oct 20147:00 amRNSResult of Proposed Share Issue
30th Sep 20146:05 pmRNSTR-1: Notification of Major Interest In Shares
24th Sep 20141:56 pmRNSPublication of Prospectus
24th Sep 20147:00 amRNSProposed Share Issue and Notice of EGM
4th Sep 201411:46 amRNSNOTIFICATION OF MAJOR INTEREST IN SHARES
21st Aug 20147:00 amRNSAcquisition and funding agreement
14th Aug 201411:14 amRNSNotification of Major Interest in Shares
13th Aug 20145:08 pmRNSNotification of Major Interest in Shares
31st Jul 20147:00 amRNSInterim Management Statement
23rd Jul 20147:00 amRNSAcquisition of Medical Centre
22nd Jul 20145:29 pmRNSAnnual Information Update
22nd Jul 20144:57 pmRNSResult of AGM
1st Jul 201412:16 pmRNSTotal Voting Rights and Issued Share Capital
1st Jul 20149:24 amRNSNOTIFICATION OF MAJOR INTEREST IN SHARES
23rd Jun 20145:15 pmRNSNotification of Major Interest in Shares
20th Jun 20143:34 pmRNSAnnual Report & Notice of AGM
13th Jun 20147:00 amRNSAcquisition of 28 medical centres for £107 million
10th Jun 20149:44 amRNSConfirmation of Quarterly Interim Dividend
23rd May 20147:00 amRNSPreliminary results for year ended 31 March 2014
2nd Apr 201411:42 amRNSConfirmation of Quarterly Interim Dividend
4th Mar 201412:00 pmRNSDirector/PDMR Shareholding
14th Feb 20147:00 amRNSInterim Management Statement
13th Feb 201411:58 amRNSNotification of Major Interest in Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.